.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Breast Cancer: A Continuum of Care

EP. 1: Breast Cancer: Genomic Testing for Adjuvant Therapy

February 22nd 2017

EP. 2: MINDACT Trial Design and Results in Breast Cancer

February 22nd 2017

EP. 3: Breast Cancer: Genomic Testing

February 22nd 2017

EP. 4: Comparison of Prognostic Tests in Breast Cancer

February 22nd 2017

EP. 5: Breast Cancer: Extended Adjuvant Endocrine Therapy

February 22nd 2017

EP. 6: FALCON Trial Data in HR+ Metastatic Breast Cancer

February 22nd 2017

EP. 7: Ribociclib for HR+ Advanced Breast Cancer

February 22nd 2017

EP. 8: Emerging Role of Abemaciclib for HR+ Advanced Breast Cancer

February 22nd 2017

EP. 9: Everolimus for HR+ Metastatic Breast Cancer

February 22nd 2017

EP. 10: PI3K Inhibitors in HR+ Metastatic Breast Cancer

February 22nd 2017

EP. 11: HER2-Targeted Therapy in Early Stage HER2+ Breast Cancer

February 22nd 2017

EP. 12: Extended Adjuvant Therapy for HER2+ Early Breast Cancer

February 22nd 2017

EP. 13: Treating HER2+ Metastatic Breast Cancer

February 22nd 2017

EP. 14: BRCA1/2 Status and Homologous Repair Deficiency in TNBC

February 22nd 2017

EP. 15: Immunotherapy for TNBC

February 22nd 2017

EP. 16: Antibody-Drug Conjugates for TNBC

February 22nd 2017